We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"All six children in the study who developed medullary thyroid carcinoma had a germline RET mutation. Forty percent of children with retinoblastoma ..."
"Cancer patients, except those with medullary thyroid carcinoma, can also take the drug, provided they stay hydrated to avoid pancreatitis. Acharya ..."
"... medullary thyroid carcinoma, a rare but aggressive form of thyroid cancer. People who inherit certain RET mutations face an extremely high ..."
"GLP-1 Receptor Agonists: Contraindications for Medullary Thyroid Cancer and Multiple Endocrine Neoplasia Type 2. Do not use GLP-1 receptor ..."
"Australians with advanced or metastatic medullary thyroid cancer caused by a RET mutation can now access the targeted therapy RETEVMO (selpercatinib) ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.